Elanco Animal Health Inc.
Income Statement
| Line Item | FY2017 | FY2016 |
|---|---|---|
| Revenue | $2.89B | $2.91B |
| Cost of Revenue | $1.49B | $1.41B |
| Gross Profit | $1.40B | $1.50B |
| Gross Margin | 48.3% | 51.6% |
| Operating Expenses | ||
| Research & Development | $251.7M | $265.8M |
| SG&A Expense | $779.8M | $784.8M |
| Operating Income | $-232.6M | $-22.4M |
| Operating Margin | -8.1% | -0.8% |
| Interest Expense | $0 | $0 |
| Pretax Income | $-232.6M | $-22.4M |
| Income Tax Expense | $78.1M | $25.5M |
| Net Income | $-310.7M | $-47.9M |
| Net Margin | -10.8% | -1.6% |
| EPS (Basic) | $-1.06 | $-0.16 |
| EPS (Diluted) | $-1.06 | $-0.16 |
| Shares Outstanding (Basic) | 293.3M | 293.3M |
| Shares Outstanding (Diluted) | 293.3M | 293.3M |
| Dividends Per Share | — | — |